GEOFFREY F. COX, PH.D. - Corporate Board Profile

Vaxart, Inc.

Filing Date	Source Excerpt
2009-04-22	Geoffrey F. Cox, Ph.D., age 65, has been a director of the Company since 2000 and has served as non-executive Chairman of the Board of Directors of the Company since February 2007. The following table sets forth compensation actually paid, earned or accrued during fiscal year 2008 by the Companys directors. Geoffrey F. Cox, Ph.D. Fees Earned or Paid in Cash $96,500, Option Awards $104,400, Total $200,900.
2010-04-16	Geoffrey F. Cox, Ph.D., age 66, has been a director of the Company since 2000 and has served as non-executive Chairman of the Board of Directors of the Company since February 2007. ... Dr. Cox's extensive biotechnology industry expertise ... were among the factors considered by the Board of Directors in determining that Dr. Cox should be nominated for election as a director. ... The non-executive Chairman of the Board of Directors receives an annual retainer of $80,000. ... The following table sets forth compensation actually paid, earned or accrued during fiscal year 2009 by the Company's directors. Geoffrey F. Cox, Ph.D. Fees Earned or Paid in Cash 93,500 Option Awards 81,086 All Other Compensation 0 Total 174,586
2011-04-20	Geoffrey F. Cox, Ph.D., age 67, has been a director of the Company since 2000 and has served as non-executive Chairman of the Board of Directors of the Company since February 2007. ... The Compensation Committee currently consists of Messrs. Harvey (Chairman), Aryeh and Cox... The Nominating and Governance Committee is currently comprised of all members of the Board of Directors, with the exception of Dr. Fahim, and is chaired by Dr. Cox... The following table sets forth compensation actually paid, earned or accrued during fiscal year 2010 by the Company's directors. Geoffrey F. Cox, Ph.D. 76,002 Fees Earned or Paid in Cash, 136,088 Option Awards, 9,998 Stock Awards, 222,088 Total.
2013-10-01	Geoffrey F. Cox, Ph.D., age 69, has served on the Company’s Board of Directors since 2000. ... Dr. Cox’s extensive biotechnology industry expertise, including his many years of experience as an executive officer and board member of publicly-traded biotechnology companies, led to the conclusion that he should serve on the Company’s Board of Directors. ... Compensation Committee Member. ... Nominating and Corporate Governance Committee Chair. ... Director Compensation Table shows total compensation of $69,157.
2014-10-03	Geoffrey F. Cox, Ph.D., age 70, has served on the Company’s Board of Directors since 2000. Dr. Cox is an independent consultant and a member of the board of directors of QLT Inc., a publicly-traded company, as well as a director of Gallus Biopharmaceuticals LLC and Lakewood-Amedex, LLC.
2015-09-30	The members of the Compensation Committee are Dr. Fox (Chair), Mr. Dougherty and Dr. Cox. The Board has determined that all members of the Compensation Committee are independent directors under the Nasdaq listing standards.
2016-09-27	Geoffrey F. Cox, Ph.D., age 72 has served on the Company’s Board of Directors since 2000. ... Dr. Cox’s extensive biotechnology industry expertise, including his many years of experience as an executive officer and board member of publicly-traded biotechnology companies, led to the conclusion that he should serve on the Company’s Board of Directors.
2018-02-26	Geoffrey F. Cox, Ph.D., has served as a member the board of directors since 2000. The following table shows his committee memberships: Audit Committee and Compensation Committee. Director Compensation 2017: $58,315.
2019-03-11	Geoffrey F. Cox, Ph.D. has served as a member of the board of directors since 2000. He was a director (2000-2012) and the Non-Executive Chairman (2007 to 2012) of Nabi Biopharmaceuticals, Inc. prior to its merger with Biota Pharmaceuticals, Inc. (subsequently Aviragen) in 2012 and then with Vaxart in 2018.